Molecular Diagnostics

Consumer genetic testing may misrepresent breast cancer risk: Study

Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.

September 21, 2023

Rome Therapeutics raises $72M in series B financing

Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”

September 20, 2023

Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study

Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.

September 21, 2023

Researchers develop signature for scoring thyroid cancers

A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.

September 20, 2023

Broken String Biosciences raises $15M in series A financing round

Broken String Biosciences has closed a $15 million series A financing round.

September 19, 2023

Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer

Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.

September 18, 2023

Electronic DNA nanoballs detection enables fast, accurate, cheap pathogen detection

Electronic detection of DNA nanoballs could enable fast, accurate, and cheap identification of pathogens, according to a paper published in Science Advances.

September 18, 2023

Castle Biosciences Pittsburgh lab receives N.Y. state permit

Castle Biosciences has received a clinical laboratory permit from the New York State Department of Health for its Pittsburgh laboratory.

September 13, 2023

Agilent to sell Resolution Bioscience to Exact Sciences

Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.

September 12, 2023

Identification of hundreds of blood pressure genes lays foundation for hypertension drugs

Researchers have found hundreds of genes that may affect blood pressure, setting the stage for further studies that could inform the development of new treatments for hypertension.

September 12, 2023

Illumina names new CEO

Illumina has appointed Agilent Technologies’ Senior Vice President Jacob Thaysen as CEO, effective September 25.

September 8, 2023

Actome outlines sequencing expansion plans as EU funding kicks in

Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”

September 7, 2023

Page 1 of 187

Next Page